Patents by Inventor Allison LUO

Allison LUO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS, SYSTEMS, AND KITS FOR TREATMENT OF INFLAMMATORY DISEASES TARGETING TL1A
    Publication number: 20260066079
    Abstract: Provided are methods, systems, and kits for selecting a subject for treatment with an inhibitor of Tumor necrosis factor-like cytokine 1A (TL1A) activity or expression based on a presence of one or more genotypes associated with a positive therapeutic response to the inhibitor of TL1A. Also provided are methods, systems and kits for detecting the one or more genotypes described herein.
    Type: Application
    Filed: November 20, 2023
    Publication date: March 5, 2026
    Applicant: Prometheus Biosciences, Inc.
    Inventors: Fadi Towfic, Yong Wang, Olivier Laurent, Jiandong Lu, Allison Luo
  • ANTI-TL1A ANTIBODY COMPOSITIONS AND METHODS OF TREATMENT IN THE LUNG
    Publication number: 20240336691
    Abstract: Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of diseases and/or conditions in the lung.
    Type: Application
    Filed: February 17, 2022
    Publication date: October 10, 2024
    Inventors: Allison LUO, Olivier LAURENT, Ernesto J. MUNOZ, Janine BILSBOROUGH, Bradley HENKLE, Stephan R. TARGAN, Dermot P. MCGOVERN
  • COMPOSITIONS COMPRISING HUMANIZED ANTIBODIES TO TNF-LIKE LIGAND 1A (TL1A) AND USES THEREOF
    Publication number: 20240309104
    Abstract: Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).
    Type: Application
    Filed: February 17, 2022
    Publication date: September 19, 2024
    Inventors: Allison LUO, Lauren OTSUKI, Mark MANNING, Robert PAYNE, Olivier LAURENT, Janine BILSBOROUGH, Bradley HENKLE, Stephan R. TARGAN
  • TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A CHEMOKINE/CHEMOKINE RECEPTOR INHIBITOR
    Publication number: 20220071894
    Abstract: This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor.
    Type: Application
    Filed: March 8, 2021
    Publication date: March 10, 2022
    Inventors: Mitchell Lawrence Jones, Christopher Loren Wahl, Sharat Singh, Harry Stylli, Allison Luo
  • Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
    Patent number: 10980739
    Abstract: This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: April 20, 2021
    Assignee: Progenity, Inc.
    Inventors: Mitchell Lawrence Jones, Christopher Loren Wahl, Sharat Singh, Harry Stylli, Allison Luo
  • TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A CHEMOKINE/CHEMOKINE RECEPTOR INHIBITOR
    Publication number: 20200170937
    Abstract: This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor.
    Type: Application
    Filed: December 14, 2017
    Publication date: June 4, 2020
    Applicant: Progenity, Inc.
    Inventors: Mitchell Lawrence JONES, Christopher Loren WAHL, Sharat SINGH, Harry STYLLI, Allison LUO